Back
Medpace Holdings Vs. Charles River Laboratories International Industry Stock Comparison
Buy
65
MEDP
Medpace Holdings
Last Price:
390.13
Seasonality Move:
33.63%
Buy
55
CRL
Charles River Laboratories International
Last Price:
227.95
Seasonality Move:
7.56%
Buy
65
Medpace Holdings (MEDP)
is a Buy
Is Medpace Holdings a Buy, Sell or Hold?
- The current Medpace Holdings [MEDP] share price is $390.19. The Score for MEDP is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- MEDP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Charles River Laboratories International (CRL)
is a Buy
Is Charles River Laboratories International a Buy, Sell or Hold?
- The current Charles River Laboratories International [CRL] share price is $228.12. The Score for CRL is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MEDP Stock Price Chart
What is Medpace Holdings's stock price today?
-
The Medpace Holdings share price today is $390.19
The current trend is moderately bearish and MEDP is experiencing selling pressure, which indicates risk of future bearish movement.
CRL Stock Price Chart
What is Charles River Laboratories International's stock price today?
-
The Charles River Laboratories International share price today is $228.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRL is experiencing slight buying pressure.
MEDP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.58 | Buy |
| Relative Strength Index (14 RSI): | 48.4 | Sell |
| Chaikin Money Flow: | -208306 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (383.37 - 402.67) | Sell |
| Bollinger Bands (100): | (312.83 - 407.65) | Buy |
CRL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.43 | Sell |
| Relative Strength Index (14 RSI): | 39.06 | Sell |
| Chaikin Money Flow: | 184480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (227.53 - 243.77) | Sell |
| Bollinger Bands (100): | (220.18 - 257.24) | Sell |
MEDP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 395.09 | Sell |
| 20-day SMA: | 390.85 | Sell |
| 50-day SMA: | 397.44 | Sell |
| 200-day SMA: | 311.1 | Buy |
| 8-day EMA: | 394.21 | Sell |
| 20-day EMA: | 393.82 | Sell |
| 50-day EMA: | 386.79 | Buy |
| 200-day EMA: | 323.68 | Buy |
CRL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 232.64 | Sell |
| 20-day SMA: | 232.19 | Sell |
| 50-day SMA: | 249.84 | Sell |
| 200-day SMA: | 217.72 | Buy |
| 8-day EMA: | 232.02 | Sell |
| 20-day EMA: | 235.41 | Sell |
| 50-day EMA: | 240.21 | Sell |
| 200-day EMA: | 226.68 | Buy |
Medpace Holdings Earnings Growth & MEDP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.72 per share, a decrease next quarter of $0.05 per share, an increase this year of $2.42 per share, and an increase next year of $1.97 per share.
Charles River Laboratories International Earnings Growth & CRL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.65 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.22 per share, and an increase next year of $1.44 per share.
Medpace Holdings Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Charles River Laboratories International Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||